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Abstract
Gene-gene interactions are often regarded as playing significant roles in influencing variabilities
of complex traits. Although much research has been devoted to this area, to date a comprehen-
sive statistical model that addresses the various sources of uncertainties, seem to be lacking. In
this paper, we propose and develop a novel Bayesian semiparametric approach composed of fi-
nite mixtures based on Dirichlet processes and a hierarchical matrix-normal distribution that can
comprehensively account for the unknown number of sub-populations and gene-gene interactions.
Then, by formulating novel and suitable Bayesian tests of hypotheses we attempt to single out the
roles of the genes, individually, and in interaction with other genes, in case-control studies. We
also attempt to identify the significant loci associated with the disease. Our model facilitates a
highly efficient parallel computing methodology, combining Gibbs sampling and Transformation
based MCMC (TMCMC). Application of our ideas to biologically realistic data sets revealed quite
encouraging performance. We also applied our ideas to a real, myocardial infarction dataset, and
obtained interesting results that partly agree with, and also complement, the existing works in this
area, to reveal the importance of sophisticated and realistic modeling of gene-gene interactions.
Keywords: Case-control study; Dirichlet process; Gene-gene interaction; Myocardial infarction;
Parallel processing; Transformation based MCMC.
1. INTRODUCTION
Isolated evaluation of individual single nucleotide polymorphisms (SNPs) for their association
with complex diseases in genome wide association studies (GWAS) have succeeded in explaining
only small proportions of genetic inheritances; see Larson & Schaid (2013) and the references
therein. It is now well-known that some genes interact with one another in complex networks,
and that such interactions may influence genetic variations of complex traits (see Bonetta (2010),
Moore (2003), Howard, Koppelman, Xu, Zheng, Postma, Meyers & Bleecker (2002), Li & Cui
(2012), Moore & Williams (2002)). It is hence anticipated that the want of significant success
of GWAS may perhaps be due to the lack of a sophisticated statistical model incorporating the
scientific understanding about gene-gene interactions (see Cordell (2009)) into genomic profiling,
that may help in understanding the biological and biochemical pathways behind complex diseases;
see Yi (2010).
One of the main challenges faced at the very onset of investigating genetic interactions is that
of non-uniqueness in the definition of epistasis or gene-gene interactions. According to Phillips
(2008), biologically, epistasis can be categorised as functional epistasis and compositional epis-
tasis, both of which differ widely from the statistical definition of epistasis. While functional
epistasis indicates protein-protein interactions at molecular level, any disruption of which is ex-
plained by a genetic consequence, compositional epistasis refers to blocking of one allelic effect
by an allele at another locus. Fisher (1918) (see also Kempthorne (1954)) defined statistical inter-
action among the genes as deviations from additive marginal effects of individual genes. Although
VanderWeele (2009) derived some strong empirical conditions under which statistical interactions
correspond to compositional epistasis, a prevailing opinion reflected in both genetic and epidemio-
logical literature suggests limitations of the tests based on Fisher’s statistical definition of epistasis
in explaining the gene-gene interactions in the biological sense of the term. According to Cordell
(2002) and Wang, Elston & Zhu (2010), although statistical and biological interpretations of inter-
action need not be compatible with each other, quantification of biological interaction should be
based on statistical concepts of interactions.
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Several case-control studies, defining gene-gene interactions via SNP-SNP interactions have
been performed (Yi, Kaklamani & Pasche (2011)), assuming that interaction between any two
genes are in fact caused by interactions between their respective SNPs. Apart from not considering
the genes as functional units, these linear model-based statistical analyses suffer from very high
testing dimensionality and become computationally burdensome because of the very large number
of marginal and pairwise interaction effects to be incorporated in the linear model when dealing
with a large number of SNPs. The relevant statistical interaction models existing in the case-
control literature point towards the following trade-off: dimension reduction by working at the
gene-level makes computation feasible, but at the cost of useful SNP-level information (see Larson
& Schaid (2013)), while working at SNP-level promises all the necessary information but at the
cost of enormous computational burden (see also Musameh, Wang, Nelson, C.L-Ganella, Debiec,
Subirana, Elosua, Balmforth, Ball, Hall, Kathiresan, Thompson, Lucas, Samani & Tomaszewski
(2015)).
The aforementioned difficulties in the forms of trade-offs can be traced back to additive model-
ing strategies. Indeed, even with a small number of SNPs, the traditional linear model is constituted
of a very large number of terms consisting of the marginal and interaction effects at the SNP level.
Attempts to incorporate the genes as functional units in the model necessarily calls for sacrifice of
useful SNP-level information, while principal components analysis for dimension reduction make
genetic interpretation difficult. The linear modeling strategy based on Fisher’s statistical definition
of epistasis can also be questioned on the ground of oversimplicity, since functionally, gene-gene
interactions may involve very complex physical interplay among proteins as gene products (Wang
et al. (2010)). Moreover, in linear models the main effects and the interaction effects are estimated
from the genotype data and then onwards assumed to be non-random covariates. More holistic ap-
proaches should be concerned with postulating highly structured joint distributions of the complex
genotype data.
A further drawback of the existing interaction models is that they often ignore multiple sub-
populations that the genotype data usually arise from. Indeed, for different sub-populations, the
genes (or SNPs) may interact differently, which adds further complexity to the complicated func-
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tional form of epistasis. Bhattacharjee, Wang, Ciampa, Kraft, Chanock, Yu & Chatterjee (2010)
empirically demonstrate that methods ignoring population sub-structures can incur severe bias
leading to large-scale false positives. The fact that the number of sub-populations is not usually
known is a further challenging issue that needs to be considered, as one must coherently and care-
fully account for the uncertainty associated with the unknown number of sub-populations.
The criticisms of the interaction models existing in the case-control literature motivated us to
propose a new and general Bayesian model composed of mixture distributions based on Dirich-
let processes, incorporating the effects due to complex genetic interactions through hierarchical
matrix-normal-inverse-Wishart distribution. Furthermore, we develop novel Bayesian hypotheses
testing procedures and associated methodologies to investigate the effects of genes on complex
diseases in the context of case-control dataset arising from a possibly stratified population of geno-
types. In what follows we investigate only the genetic effects on complex diseases, without taking
into account the environmental effects (but see Bhattacharya & Bhattacharya (2017b) and Bhat-
tacharya & Bhattacharya (2017a)).
The rest of our paper is structured as follows. In Section 2 we introduce our proposed Bayesian
semiparametric model, and in Section 3 we propose and develop a novel Bayesian hypothesis
testing procedure for detecting the roles of genes in case-control studies. In Section 4 we present a
brief discussion on validation of our model and methodologies with biologically realistic simulated
data sets, the details of which are provided in the supplement, described below. In Section 5 we
conduct a detailed analysis of case-control data on early onset of Myocardial Infarction obtained
from dbGap, comparing and contrasting our findings with the existing results. We summarize our
work and make concluding remarks in Section 6.
Additional details are provided in the supplement, whose sections and figures have the prefix
“S-” when referred to in this paper.
3
2. A NEW BAYESIAN SEMIPARAMETRIC MODEL FOR GENE-GENE
INTERACTIONS
Before we introduce our proposed model, we first detail the type of genotype and phenotype data
that we are interested in.
2.1 Genotype data
For s = 1, 2 denoting the two chromosomes, let xsijkr = 1 and x
s
ijkr = 0 indicate the presence
and absence of the minor allele of the i-th individual, j-th gene, the k-th group, and r-th locus;
i = 1, . . . , Nk; j = 1, . . . , J ; k = 0, 1, with k = 1 denoting case, and r = 1, . . . , Lj .
In this paper, we shall concern ourselves with data sets of the aforementioned type. However,
for our model, which we introduce below, it is obvious that data sets consisting of only minor allele
counts at each locus contains exactly the same information as the above described data type.
2.2 Mixture models driven by Dirichlet processes
Given any (j, k), let xijkr = (x1ijkr, x
2
ijkr), and X ijk = (xijk1,xijk2, . . . ,xijkLj). We assume that
for every triplet (i, j, k),X ijk are independently distributed with mixture probability mass function
with a maximum of M components, given by
[X ijk] =
M∑
m=1
pimjk
Lj∏
r=1
f (xijkr|pmjkr) , (2.1)
where f (·|pmjkr) is the probability mass function of independent Bernoulli distributions, given by
f (xijkr|pmjkr) = {pmjkr}x
1
ijkr+x
2
ijkr {1− pmjkr}2−(x
1
ijkr+x
2
ijkr) . (2.2)
In (2.1) and throughout the paper we use the notation [·] to denote the probability distribution as
well as the probability mass or density functon. Using allocation variables zijk, with probability
distribution
[zijk = m] = pimjk, (2.3)
for i = 1, . . . , Nk and m = 1, . . . ,M , (2.1) can be represented as
[X ijk|zijk] =
Lj∏
r=1
f
(
xijkr|pzijkjkr
)
. (2.4)
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We may assume appropriate Dirichlet distribution priors on (pi1jk, . . . , piMjk) for j = 1, . . . , J ;
k = 0, 1. However, as investigated in Majumdar, Bhattacharya, Basu & Ghosh (2013), the Dirich-
let distribution often yields very small values of the probabilities pimjk, thereby tending to underes-
timate the true number of mixture components. On the other hand, setting pimjk = 1/M exhibited
much better performance. Therefore, in this work, we set pimjk = 1/M , for m = 1, . . . ,M , and
for all (j, k).
Letting pmjk =
(
pmjk1, pmjk2, . . . , pmjkLj
)
, we further assume that
p1jk,p2jk, . . . ,pMjk
iid∼ Gjk; (2.5)
Gjk ∼ DP (αjkG0,jk) , (2.6)
where DP (αjkG0,jk) stands for Dirichlet process with expected probability measure G0,jk having
precision parameter αjk. We assume that underG0,jk, for m = 1, . . . ,M and r = 1, . . . , Lj ,
pmjkr
iid∼ Beta (ν1jkr, ν2jkr) . (2.7)
Thus, given a particular pair (j, k), our mixture model has the same structure as adopted by
Majumdar et al. (2013) for inference on population structure. Discreteness of Dirichlet processes
cause coincidences among the parameter vectors of PMjk =
{
p1jk,p2jk, . . . ,pMjk
}
with positive
probability, so that, with positive probability, the actual number of mixture components in (2.1)
falls below M , the maximum number of components, the mixing probabilities taking the form
M∗/M , where 1 ≤ M∗ ≤ M . See Majumdar et al. (2013), Mukhopadhyay, Bhattacharya &
Dihidar (2011), Mukhopadhyay, Roy & Bhattacharya (2012), Bhattacharya (2008), for the details.
In fact, we marginalize overGjk to arrive at the well-known Polya urn distribution of PMjk:[
pmjk|PMjk\{pmjk}
] ∼ αjk
αjk +M − 1G0,jk
(
pmjk
)
+
1
αjk +M − 1
M∑
m′ 6=m=1
δpm′jk
(
pmjk
)
,
(2.8)
where δpm′jk(·) denotes point mass at pm′jk. The property of coincidences among the parameter
vectors is clearly preserved by the Polya urn scheme.
Observe that, after coincidences among the mixture components, the pairs (j, k) come to be
associated with different mixtures, with different numbers of components. This is reasonable,
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because, the distributions of the genotypes for the gene j of any two individuals belonging to the
same subpopulation but with different case-control status, that is, (j, k = 0) and (j, k = 1) are
expected to correspond to different mixtures under significant genetic effect on the disease (see
Antonyuk & Holmes (2009)).
We have discussed a rule of thumb for the choice of M as well as α in Section S-1 of the
supplement, following whch we set M = 30 and αjk = 10 in our applications.
2.3 Incorporating the gene-gene and SNP-SNP interactions through appropriate modeling
of the parameters
2.3.1. Modeling the parameters of G0,jk Taking into consideration the SNP-SNP depen-
dence, which may exist within each gene and also among the genes, we model the Beta parameters
ν1jkr and ν2jkr of (2.7) as follows:
For r = 1, . . . , L, where L = max{Lj; j = 1, . . . , J}, and for every (j, k),
ν1jkr = exp (ur + λjk) ; (2.9)
ν2jkr = exp (vr + λjk) . (2.10)
Allowing ur and vr to be different ensures that the mean of pmjkr under G0,jk depends upon the
r-th SNP. We further assume that for r = 1, . . . , L,
ur
iid∼ N(0, 1); (2.11)
vr
iid∼ N(0, 1). (2.12)
We found that the Gaussian priors on ur and vr with other means and variances did not yield sig-
nificantly different results, thus pointing towards in-built prior robustness in our modeling strategy.
Subsequently, using matrix-normal distribution as a prior onλ = {λjk; j = 1, . . . , J, k = 0, 1}
we incorporate the SNP-wise dependence in a gene. Moreover, the SNPs associated with differ-
ent genes are also dependent through the dependence structure among the genes imposed by the
matrix-normal prior.
Note that allowing ur and vr to be shared by all the genes creates the impression that the labels
of the loci are not exchangeable. However, our matrix-normal-inverse-Wishart prior ensures that
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this is not the case, and that for any two genes j1 and j2, and k1, k2 ∈ {0, 1}, ur + λj1k1 (or
vr + λj1k1) and ur + λj2k2 (or vr + λj2k2), and hence their exponentiated versions, are independent
with positive probability, given the data. This is elucidated in Section S-3 of the supplement in
light of the matrix-normal-inverse-Wishart prior. We vindicated this mathematical argument with
simulation studies; see Section 4 (details provided in Section S-7 of the supplement). Specifically,
we conducted extra simulation studies after randomly permuting the labels of the loci of each gene
and re-analyzed each such data set. The results, provided in Section S-7 of the supplement, are
consistent with those obtained without permuting the labels.
2.3.2. Matrix normal prior for λ We consider the following model for λ:
λ ∼ N (µ,A⊗Σ) . (2.13)
Re-writing the 2J-dimensional vector λ as a J × 2 matrix Λ, (2.13) can be represented as a matrix
normal distribution with mean matrix µJ×2, left covariance matrix A and right covariance matrix
Σ, having probability density function
pi(Λ) =
exp
[
−tr
{
Σ−1 (Λ− µ)T A−1 (Λ− µ)
}]
(2pi)J |A|2 |Λ|J . (2.14)
We note that the k-th column of Λ, which we denote by Λcol,k, follows the multivariate normal
distribution:
Λcol,k ∼ NJ
(
µcol,k, σkkA
)
, (2.15)
where µcol,k is the k-th column of µ. The covariance matrix between Λcol,k1 and Λcol,k2 is given
by
cov
(
Λcol,k1 ,Λcol,k2
)
= σk1k2A. (2.16)
Similarly, the j-th row of Λ, which we denote by Λrow,js , has the following multivariate normal
distribution:
Λrow,j ∼ N2
(
µrow,j, ajjΣ
)
, (2.17)
µrow,j being the j-th row of µ. Also,
cov
(
Λrow,j1 ,Λrow,j2
)
= aj1j2Σ. (2.18)
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In our applications we chose µ = 0.
The essence of the matrix normal distribution is to offer a dependence structure among the
genes. Given case-control status k, the dependence structure associated with the genes is provided
byA, while the matrix Σ represents the dependence between the genotype distribution of the cases
and controls, given any particular gene.
2.3.3. Priors onA and Σ We assume that
A ∼ IW (ξ,A0) , (2.19)
where IW (ξ,A) stands for Inverse-Wishart distribution with degrees of freedom ξ (≥ J) and
positive definite scale matrixA. The density function is given by
pi(A) ∝ |A|−( ξ+J+12 ) × exp
{
−1
2
tr
(
A0A
−1)} . (2.20)
We further assume that
Σ ∼ IW (ζ,Σ0) , (2.21)
where the degrees of freedom ζ satisfies ζ (≥ 2) and Σ0 is a 2 × 2 positive definite matrix; the
density function is given by
pi(Σ) ∝ |Σ|−( ζ+32 ) × exp
{
−1
2
tr
(
Σ0Σ
−1)} . (2.22)
For our applications, we set ξ = J + 2 and ζ = 4. These choices are the minimum values such that
the prior expectations of A and Σ are well-defined. Choices of A0 and Σ0 are detailed in Section
S-2 of the supplement.
A schematic representation of our model and the parallel processing algorithm is provided
in Figure 2.1. Details of our parallel processing algorithm are provided in Section S-4 of the
supplement.
8
CASES  (jth Gene) CONTROLS (jth Gene)
.
.
.
.
.
.
Z1 Z2 … Zn1 Z1 Z2 … Zn1
Z1 Z2 … Zn1 Z1 Z2 … Zn1
α G2
G02
α GJ
G0J
α GJ
G0J
Gibbs
Sampling GibbsSampling
Gibbs
Sampling
Gibbs
Sampling
Updating , A &using TMCMC
Processor 0 Processor 1
Processor 2 Processor 3
Processor 0
Figure 2.1: Schematic diagram for our model and parallel processing idea: The arrows in the
diagram represent dependence between the variables. The ranks of the processors updating the
sets of parameters in parallel using Gibbs sampling are also shown. Once the other parameters are
updated in parallel, the interaction parameters are updated using TMCMC by the processor with
rank zero.
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3. DETECTION OF THE ROLES OF GENES IN CASE-CONTROL STUDIES
3.1 Formulation of a Bayesian hypothesis testing procedure
In order to investigate if genes have any significant effect on case-control, it is pertinent to test
H0 : h0j = h1j; j = 1, . . . , J, (3.1)
versus
H1 : not H0, (3.2)
where
h0j(·) =
M∑
m=1
pimjk=0
Lj∏
r=1
f
(·|prmjk=0) (3.3)
h1j(·) =
M∑
m=1
pimjk=1
Lj∏
r=1
f
(·|prmjk=1) . (3.4)
If h0j and h1j are not significantly different, then it is plausible to conclude that the role of genes
is not significant in the case-control study.
In a nutshell, testing the hypothesis in (3.1)-(3.4) requires some appropriate divergence mea-
sure between h0j and h1j and if d(h0j, h1j) denotes the divergence, then H0 is to be accepted for
appropriately large posterior probability of the event that max
1≤j≤J
d(h0j, h1j) is small.
In our situation, simultaneous consideration of a large number of genes, involving thousands
of SNPs renders the existing measures of divergence practically infeasible to compute. For details,
see Section S-5 of the supplement. This compels us to seek alternative measures of divergence
that are also amenable to efficient computation. In the mixture context, a natural measure is the
discrepancy between the clusterings associated with the two mixture distributions (Mukhopadhyay
et al. (2011), Ghosh, Dihidar & Samanta (2009)). However, since clusterings do not account for the
magnitudes of the parameters, insignificant difference between the clusterings does not necessarily
imply insignificant difference between the associated mixture densities. It is worth noting that even
the Euclidean metric alone is not appropriate – since mixture densities are invariant with respect to
permutations of the parameter components, large Euclidean distances between parameter vectors
need not imply large difference between the densities. Thus, we propose to use the clustering
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based ideas in conjunction with ideas based on the Euclidean metric, appropriately modified for
mixture densities. Indeed, if the clusterings associated with the mixture densities are known to be
of insignificant difference, then insignificant Euclidean divergence between the parameter vectors
does imply insignificant difference between the mixture densities. Details of all these issues are
provided in Section S-6 of the supplement.
3.2 Formal Bayesian hypothesis testing procedure integrating the above developments
With the clustering metric dˆ provided in Section S-6 of the supplement, let us define
d∗ = max
1≤j≤J
dj,
where
dj = dˆ (PMjk=0,PMjk=1)
is the distance between the clusterings PMjk=0 =
{
p1jk=0,p2jk=0, . . . ,pMjk=0
}
and PMjk=1 ={
p1jk=1,p2jk=1, . . . ,pMjk=1
}
, for j = 1, . . . , J . With this, we first test
H0d∗ : d
∗ < ε versus H1d∗ : d∗ ≥ ε, (3.5)
for reasonably small choice of ε (> 0). Acceptance of H0d∗ indicates that clusterings associated
with h0j and h1j have insignificant difference, for every j = 1, . . . , J . If H0d∗ is rejected, then it
follows that for at least one j ∈ {1, . . . , J}, the clustering difference is significant.
If H0d∗ is rejected, then it entails that the clusterings associated with the mixture densities for
case and control are significantly different. This implies that the mixture densities themselves are
significantly different, so that rejection of H0d∗ leads to rejection of H0 given by (3.1).
But whenever H0d∗ is accepted based on the “0− 1” loss and the clustering metric, as already
argued, this does not necessarily imply that the mixture densities have insignificant difference. All
one can infer in this case is that differences between the associated clusterings are insignificant.
Hence, when H0d∗ is accepted, we consider a second test of the form
H0d∗E : d
∗
E < ε versus H1d∗E : d
∗
E ≥ ε, (3.6)
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where d∗E = max
1≤j≤J
dE,j; here dE,j is the Euclidean distance between
logit
(
P¯Mjk=0
)
= {logit (p¯1jk=0) , logit (p¯2jk=0) , . . . , logit (p¯Mjk=0)}
and
logit
(
P¯Mjk=1
)
= {logit (p¯1jk=1) , logit (p¯2jk=1) , . . . , logit (p¯Mjk=1)} ,
with p¯mjk =
∑Lj
r=1 pm,jkr/Lj , and logit (p¯mjk) = log {p¯mjk/(1− p¯mjk)}; see Section S-6 of the
supplement.
If H0d∗E is also accepted, then one can safely accept H0. If H0d∗E is rejected, we then consider a
third test of the form
H0d∗E,min : d
∗
E,min < ε versus H1d∗E,min : d
∗
E,min ≥ ε, (3.7)
where d∗E,min = max
1≤j≤J
dE,min,j , with dE,min,j = dE,min
(
logit
(
P¯Mjk=0
)
, logit
(
P¯Mjk=1
))
. Here
dE,min is a pseudo-metric based on the Euclidean distance; see Section S-6 for details.
If H0d∗E,min is accepted, then this implies acceptance of H0 given by (3.1). Else, H0 must be
rejected. For clarity, we present a schematic diagram of the hierarchy of the hypotheses tests in
Figure 3.1.
3.2.1. Choice of loss function for the Bayesian tests Recall that the “0− 1− c” loss function
(see, for example, Schervish (1995), for details) entails zero loss under the correct decisions, loss
1 under false acceptance of the null hypothesis and loss c (c > 0) under false rejection of the null.
Thus, we accept H0d∗ under the “0− 1− c” loss function if
P (d∗ < ε|Data) ≥ 1
1 + c
. (3.8)
Since usually there is no clear-cut way of specifying c, we shall generally select the default value
c = 1, reducing the “0− 1− c” loss function to the well-known “0− 1” loss function.
However, for the tests associated with d∗E and d
∗
E,min, which are to be considered only if H0d∗
is accepted, we shall select c much larger than 1. This is because it makes sense to provide greater
protection to the null hypothesis H0 given that the clustering test has already provided partial
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j=1,... , J
Figure 3.1: Schematic diagram for the hierarchy of Bayesian tests.
support toH0, indicating that at least the clusterings are not significantly different (see also Section
S-6 of the supplement).
Note that, under the “0−1” loss, the null hypothesis is to be accepted if its posterior probability
exceeds 1/2, while under the “0− 1− c” loss, the threshold posterior probability is 1/(1 + c). For
the hypotheses involving d∗E and d
∗
E,min we shall set c = 19 so that 1/(1 + c) = 0.05. This choice
is motivated by the 5% level of significance of classical significance tests. Some other choices will
also be briefly touched upon.
3.2.2. Choice of ε Choices of ε are expected to be problem specific. In Section S-7 of the
supplement, we discuss in detail the choices of ε in our applications. Briefly, we first consider an
appropriate null model, for instance the same model as ours but withA and Σ set to identity matrix
to reflect the null hypotheses of “no interaction” and same mixture distributions under cases and
controls for each gene for no genetic effect. We then generate case-control genotype data from the
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null model and fit our general Bayesian model to the “null data” and set ε as the 55-th percentile
of the relevant posterior distribution.
3.3 Bayesian tests for individual genetic effects when H0 is rejected
If H0 given by (3.1) is finally accepted then we may conclude that there is no significant evidence
to claim that the genes, individually, or in interaction with the other genes, are important factors in
the case-control study.
On the other hand, if H0 is rejected, then we check for significances of the individual genes by
applying our Bayesian testing procedure on the hypotheses
H0j : h0j = h1j versus H1j : h0j 6= h1j, for j = 1, . . . , J. (3.9)
For each j = 1, . . . , J , we adopt the same procedure for testing the hypothesis as for testing H0
versus H1; only d∗, d∗E and d
∗
E,min are to be replaced with dj , dE,j and dE,min,j , respectively. Note
that at each stage associated with d∗, d∗E and d
∗
E,min, the Bayesian hypotheses testing framework
is equivalent to a Bayesian multiple testing paradigm. Specifically, testing H0dj : dj < ε versus
H1dj : dj ≥ ε for j = 1, . . . , J using our Bayesian methods is equivalent to minimizing the
Bayes risk of the additive “0-1” loss function, and the subsequent Bayesian tests for the hypotheses
H0dE,j : dE,j < ε versus H1dE,j : dE,j ≥ ε and H0dE,min,j : dE,min,j < ε versus H1dE,min,j :
dE,min,j ≥ ε, for relevant indices j, are Bayesian multiple testing procedures that minimize the
Bayes risk of the additive “0-1-c” loss function, where we choose c = 19.
If H0j is accepted, then it is possible that the j-th gene is not individually influential, but
some interaction effect involving the j-th gene may be significant. To check which interactions
are significant (we may check this even if H0j is rejected, since the j-th gene may be marginally
significant as well as interactive with the other genes), one may conduct the testsH0,j,j∗ : |Ajj∗ | <
ε versus H1,j,j∗ : |Ajj∗| ≥ ε, for j∗ 6= j, Ajj∗ being the (j, j∗)-th element of A. Acceptance
of H1,j,j∗ for some (or many) j∗ 6= j, indicates which of the genes interact with the j-th gene to
contribute significantly to the underlying case-control study.
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4. VALIDATION OF OUR MODEL AND METHODOLOGIES WITH
BIOLOGICALLY REALISTIC SIMULATED DATA SETS
We evaluate our model and methodologies on data sets generated from the GENS2 software de-
signed by Pinelli, Scala, Amato, Cocozza & Miele (2012). In a nutshell, the software creates large,
biologically realistic data sets having realistic LD patterns, where risks of complex diseases are
influenced by known gene-gene and gene-environment interactions. We consider two simulated
data sets for our experiments – in the first experiment, we generate a case-control data set under
the effect of gene-gene interaction, fit our model to the data set, and test the relevant hypotheses.
We show that our model and methodology successfully captures the relevant information regarding
the effects of the individual genes, gene-gene interaction, and the number of sub-populations. We
also show that, in spite of LD, our model succeeds in capturing the close neighborhoods of the
actual disease predisposing loci (DPL) of the genes.
In the second experiment we generate a data set where disease risk is devoid of any genetic
effect and is influenced only by some environmental exposure. Application of our model and
methods to this data set again successfully captures the correct situation, clearly indicating lack of
genetic influence.
For both the simulated data sets we perform simulation experiments by randomly permuting
the labels of the loci of each gene. For both cases we obtain results associated with the permuted
labels that completely support those obtained from the original simulated data sets.
Details are provided in Section S-7 of the supplement.
5. APPLICATION OF OUR MODEL AND METHODOLOGIES TO A REAL,
CASE-CONTROL DATASET ON MYOCARDIAL INFARCTION
Application of our ideas to a case-control dataset on early-onset of myocardial infarction (MI)
from MI Gen study, obtained from the dbGaP database (http://www.ncbi.nlm.nih.gov/gap), led
to some interesting findings.
MI (more commonly, heart attack), is a complex disease and is a leading cause of death and
disability all over the world. Much investigation has been carried out for detecting the genetic
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causes of myocardial infarction, all of which are based on the assumption that the main contributory
factors for the disease are the mutations in the proteins associated with the pathophysiology of
atherosclerosis (see Erdmann, Linsel-Nitschke & Schunkert (2010)).
Although the GWA studies have revealed a lot of genetic information regarding MI (an overview
of the main results can be found in Erdmann et al. (2010)), only a very few of the detected genes are
related to traditional risk factors (LDL-cholesterol, diabetes and LP[a] etc.), and the other genes
increase the risk by pathogenetic mechanisms that are not yet properly understood. Despite much
success in deciphering the marginal effects of many SNPs, not much has been achieved in the
gene-gene interaction front. According to Musameh et al. (2015), burden of multiple testing ren-
ders the standard GWAS samples underpowered to detect such effects, while Lucas, Lluis-Ganella,
Subirana, Masameh & Gonzalez (2012) blame the complexity of the epistatic effects as a reason
behind the difficulty in detecting them.
5.1 Data description
The MI Gen data obtained from dbGaP broadly represents a mixture of four sub-populations:
Caucasian, Han Chinese, Japanese and Yoruban. Since the names of the genes were not provided in
the dataset, SNPs were mapped on to the corresponding genes using the Ensembl human genome
database (http://www.ensembl.org/). However, technical glitches prevented us from obtaining
information on the genes associated with all the markers. As such, we could categorize 446765
markers out of 727478 with respect to 37233 genes.
For our analysis, we considered a set of SNPs that are found to be individually associated with
different cardiovascular end points like LDL cholesterol, smoking, blood pressure, body mass etc.
in various GWA studies published in NHGRI catalogue and augmented this set further with another
set of SNPs found to be marginally associated with MI in the MIGen study (see Lucas et al. (2012)).
Our study also includes SNPs that are reported to be associated with MI in various other studies,
see Erdmann et al. (2010), Qi, Ma, Qi, Hartiala, Allayee & Campos (2011) and Wang, Rao, Shen,
Li, Moliterno, Newby, Rogers, Cannata, Zirzow, Elston & Topol (2004). In all, we obtained 271
SNPs. Unfortunately, only 33 of them turned out to be common to the SNPs of our original MI
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dataset on genotypes, which has been mapped on to the genes using the Ensembl human genome
database. However, we included in our study all the SNPs associated with the genes containing the
33 common SNPs. Specifically, our study involves the genotypic information on 32 genes covering
1251 loci, including the 33 previously identified loci for all the 6042 individuals available in our
dataset.
Categorization of the case-control genotype data into the four sub-populations, each of which
are likely to represent several further and rather varied sub-populations genetically, implies that
the maximum number of mixture components must be fixed at some value much higher than 4.
As before, we set M = 30 and αjk = 10 for every (j, k), to facilitate data-driven inference.
Interestingly, the distributions of the number of distinct components for αjk = 1.5 (so that the prior
mean and variance are approximately 5) were not significantly different from those of αjk = 10,
indicating prior robustness.
We chose a similar set-up for the null model. That is, we chose the same number of genes and
the same number of loci for each gene, the same number of cases and controls, the same value
M = 30, but αjk = 1.5 for every (j, k), as in our simulation studies. We use the same priors as in
the real data set-up except that we set A and Σ to be identity matrices to ensure that the genetic
interaction is not present and set the same mixture distribution under cases and controls for each
gene to ensure the absence of genetic effects. For details see Section 4.1.2 of the supplement.
5.2 Remarks on model implementation
We implemented our parallel MCMC algorithm detailed in Section S-4 of the supplement for
posterior simulation on a VMware consisting of 60 double-threaded, 64-bit physical cores, each
running at 2.5 GHz; 50 such cores were available to us. The mixture components associated with
{(j, k) : j = 1, . . . , J ; k = 0, 1}, with J = 32, are updated in parallel, on 64 of the total 100 avail-
able threads. This is followed by updating the interaction parameters on a separate processor using
a mixture of additive and additive-multiplicative TMCMC (see Section S-4.1 of the supplement).
However, in this problem, the interaction matrixA is of order 32× 32 = 1024, and the associated
Cholesky decomposition (see Section S-4.1 of the supplement) then consists of 33× 16 = 528 pa-
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rameters. Furthermore, here λ is a 2J = 64-dimensional vector, {(ur, vr) : r = 1, . . . , L}, where
L = 207, consists of 2× 207 = 414 parameters and Σ, with its Cholesky decomposition, consists
of 3 unknowns. Hence, in all, there are 1009 interaction parameters to be updated.
Updating too many parameters in a single block, even with TMCMC, need not guarantee au-
tomatic efficiency. Here we consider updating sub-blocks of parameters at a time using additive
TMCMC. Specifically, we update Λ by updating the 64-dimensional Λk = {λjk : j = 1, . . . , J}
separately for k = 0, 1; we also update the blocks {ur : r = 1, . . . , L} and {vr : r = 1, . . . , L} and
Σ separately. Since A consists of 528 parameters, at each iteration we update only 32 randomly
chosen non-zero elements of the Cholesky factor of A using additive TMCMC. The latter is cer-
tainly a valid TMCMC strategy, which is theoretically a mixture of TMCMC strategies (see, for
example, Tierney (1994) in the context of Metropolis-Hastings), and maintains very reasonable
acceptance rate in our application.
The above parallel MCMC algorithm takes about 31 hours to yield 30, 000 iterations in our
aforementioned VMware machine. We discard the first 10, 000 iterations as burn-in. Informal
convergence diagnostics such as trace plots exhibited adequate mixing properties of our parallel
algorithm.
5.3 Results of the real data analysis
5.3.1. Influential genes obtained from our analysis Our Bayesian hypotheses testing using
both clustering metric and the Euclidean distance reveal that there is very significant overall genetic
influence on MI. Indeed, it turned out that P (d∗ < 1|Data) ≈ 0.0335 and P (d∗E < 2|Data) ≈ 0,
where 1 and 2 are the 55th percentiles of the null distributions of d∗ and d∗E . Furthermore, testing
for the effects of the genes individually using the clustering metric showed that apart from only
5 genes, namely, AP006216.10, AP006216.5, APOC1 and OR4A48P and AP00621.5, all other
genes have significant effect on MI, while with the Euclidean metric, all the genes considered
for study turned out to be significant. The posterior probabilities of the null hypotheses (of no
significant genetic influence) are shown in Figure S-4 of the supplement.
Interestingly, with respect to the Euclidean metric, all the five posterior probabilities of the
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null hypotheses associated with the aforementioned 5 genes, turned out to be empirically zero.
Thus, even though the clustering metric accepts 5 null hypotheses, the confirmation tests with
the Euclidean distances suggest rejection of all of them. We hence conclude that all the genes
considered in the study have significant effect on MI. This is in keeping with the fact that the
genes considered in our study were found to be associated with different cardiovascular endpoints
in various GWA studies or have been confirmed to play important roles in causing MI in earlier
studies.
5.3.2. Disease predisposing loci detected by our Bayesian analysis We now show that the
most influential SNPs corresponding to the maximum Euclidean distance in each of the significant
genes in our study, which we continue to refer to as the DPLs, are usually close to, and sometimes
exactly the same as the SNPs, already flagged by the earlier studies as influential.
Figure S-5 of the supplement shows the index plots of the posterior medians of the clustering
and Euclidean distances between case and control, with respect to the corresponding genes. In
terms of the clustering metric, genes HLA − DRA, RP11 − 306G20.1, PCSK9 and ADCY 5
are associated with the largest medians of the clustering distances, ranging between 0.57 and 0.68.
These genes consist of number of loci 13, 15, 14 and 32, respectively. On computing the averaged
Euclidean distances
{
drj
(
logit
(
prjk=0
)
, logit
(
prjk=1
))
; r = 1, . . . , Lj
}
, of the loci in each such
Gene-j, where the averages are taken over the TMCMC samples, we found that loci rs1051336
in HLA − DRA, rs10265116 in RP11 − 306G20.1, rs2182833 in PCSK9 and rs10934643 in
ADCY 5 have the largest distances among all the loci of the 4 respective genes. These are depicted
in Figure 5.1. Note that for the genes RP11− 306G20.1, PCSK9, and ADCY 5 to some extent,
the significant SNPs from our study are not only close to the SNPs found significant in the existing
studies (see Lucas et al. (2012)), with respect to the Euclidean distance, but also lie in their close
neighborhoods, suggesting relative agreement between the SNPs found significant in our study
and the loci considered to be influential for MI in the literature. On the other hand, rs3177928 on
HLA−DRA which has been reported by Teslovich, Musunuru, Smith, Edmondson & Stylianou
(2010) to be associated with LDL cholesterol and total cholesterol (TC) does not turn out to be a
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significant SNP for MI according to our analysis.
We now focus attention to the genes that turned out to be more influential than the remain-
ing in the sense that the medians of the Euclidean distances exceed 100. These are the genes
AP006216.10,APOC1 andOR4A48P with corresponding median Euclidean distances 110.0097,
108.4569 and 163.8584. These three genes clearly stand out in Figure S-5 (panel (b)). Each of them
consists of a single locus, and are yet highly influential.
Figures S-6, S-7 and S-8 of the supplement analyze the SNPs of some of the other influential
genes and point out the significant ones. Except for the genes MIA3 and PHACTR1, the SNPs
found significant in our study closely agree with the SNPs that are considered in the literature as
influential.
In the next section we argue that gene-gene interaction plays a vital role in explaining the
discrepancies between our findings and the existing results based on previous studies.
5.3.3. Roles of gene-gene and SNP-SNP interactions discriminating our gene findings with
influential genes reported in the literature The actual gene-gene correlations based on medians
of the posterior covariances, are shown in Figure 5.2, while Figure S-9 of the supplement depicts
the results on interaction testing. The color intensities correspond to the absolute values of the
correlations. Note that the correlation structure involves both positive and negative values where
negative correlations occur in more than 45% of the cases. A hierarchical clustering of the genes
based on the absolute values of the correlations, are provided in Figure 5.3. The vertical axis of the
diagram represents 1−|ρ|, ρ standing for the correlations shown in Figure 5.2. In a nutshell, lower
the order of the hierarchy, stronger are the correlations between the genes. For instance, Figure
5.3 shows that the correlation between genes ADAMTS9−AS2 and HMGCR is the strongest;
moreover, the correlation between ADAMTS9 − AS2 and MIA3, for example, is stronger than
the correlation between ADAMTS9− AS2 and PHACTR1.
Figures 5.2 and 5.3 depict complex interplay among the genes, many of which negatively in-
fluence each other with respect to the Euclidean distances. These gene-gene interactions also seem
to influence the SNP-wise Euclidean distances between cases and controls, revealing the effect
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Figure 5.1: Disease predisposing loci of the genes influential with respect to the clustering
metric: Plots of the Euclidean distances
{
drj
(
logitprjk=0, logitp
r
jk=1
)
; r = 1, . . . , Lj
}
against the
indices of the loci. In terms of the Euclidean distances, panels (b) and (c), and panel (d) to some
extent, show adequate agreement of our DPLs with loci known to be influential, while panel (a)
shows disagreement of our obtained DPL with the locus believed to be influential.
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(a) Colorplot of actual posterior gene-gene interaction.
Figure 5.2: Gene-gene interaction plot: Actual gene-gene interactions based on medians of the
absolute values of the posterior covariances.
22
R
AB
11
B
BU
D
13
R
BM
S1
C
EL
SR
2
PH
AC
TR
1
BD
N
F−
AS
PC
SK
9
SL
C
22
A1
C
D
KA
L1
O
R
4A
48
P
M
IA
3
AN
KS
1A
ZN
F6
52
TF
AP
2B
G
AL
N
T2
M
R
AS
W
D
R
12
AP
00
62
16
.1
0
R
P1
−9
9E
18
.2
AP
00
62
16
.5
AD
C
Y5
R
P1
1−
30
6G
20
.1
G
PA
M
C
6o
rf1
06
AP
O
C
1
C
O
L4
A1
R
P1
1−
13
6O
12
.2
AD
AM
TS
9−
AS
2
H
M
G
C
R
H
LA
−D
R
A
FT
O
SM
AR
C
A4
0.
3
0.
4
0.
5
0.
6
0.
7
0.
8
0.
9
1.
0
Correlation based Hierarchical Gene Clustering
H
ei
gh
t
Figure 5.3: Hierarchical gene clustering based on gene-gene interactions.
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of some new SNPs that failed to make their presence felt in the previous studies due to lack of
adequate dependence structure. There is another important issue to point towards in this context.
As will be seen, the correlations with respect to our current dataset are usually of small magni-
tude. This is not because the covariances are of small magnitude; indeed, they are all significantly
bounded away from zero, but the variances are of very large order, so that the covariances scaled
by the square roots of the variances, are small. These correlations, depending upon positive or
negative signs, and in conjunction with the very complex interplay among the genes and the SNPs,
are instrumental in deciding whether a SNP appears as the most influential one among a set of
SNPs in any gene. The issue is explained mathematically in Section S-8 of the supplement.
We elucidate the aforementioned issue with respect to the genes HLA − DRA, RP11 −
306G20.1, PCSK9 and ADCY 5; see Figure 5.1. Indeed, among the SNPs of HLA − DRA,
the case-control Euclidean distance associated with rs1051336, which has turned out to be influ-
ential in our analysis has maximum negative correlation of −0.02361464 with that of rs3177928,
the SNP pointed significant by Teslovich et al. (2010). Hence, it is not surprising that rs3177928
failed to be close to rs1051336 in terms of the Euclidean distance between case and control. On
the other hand, rs10265116 of RP11 − 306G20.1 is positively correlated with the literature-
based important SNP rs11556924, the correlation being 0.007653744, supporting the closeness
of the Euclidean distances between rs11556924 and rs10265116. For gene PCSK9, the corre-
lation between rs2182833, the influential SNP by our study and the literature-based rs2479409,
is −0.005999625. The consequence of this small, albeit negative correlation, is well-reflected in
panel (c) of Figure 5.1; the corresponding Euclidean distances are close but there are other SNPs,
positively correlated with rs2182833, that have larger Euclidean distances compared to that of
rs2479409. For gene ADCY 5, however, the influential SNP by our study, rs10934643 is posi-
tively correlated with the literature-based SNP rs2877716, the correlation being 0.00880905. The
fact that in spite of the positive correlation the two SNPs are not adequately close in terms of
case-control Euclidean distances, begs some explanation, which we provide next.
Interestingly, the key to this phenomenon lies in inter-genetic SNP-SNP interaction. Indeed,
OR4A48P , the most influential gene in terms of the maximum Euclidean distance, and consist-
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ing of the single locus rs7395662, exerts negative influence on rs2877716 through the negative
correlation −0.02919905, but has small and positive correlation, 0.00298559, with rs10934643.
This gene, through its only SNP, also influences the other genes via positive or negative cor-
relations. For instance, its correlations with rs1051336 and rs3177928 of HLA − DRA are
0.05828725 and −0.01058818, respectively. In other words, the former receives lot more weight
compared to the latter, so that rs1051336 becomes influential with respect to our model. For
gene RP11 − 306G20.1, its correlations with the relevant two loci rs10265116 and rs11556924,
are 0.05306113 and 0.003207612, respectively, so that both SNPs are relatively close but the for-
mer takes precedence, becoming DPL, thanks to its larger correlation with OR4A48P . For gene
PCSK9, the correlations of rs2182833 and rs2479409 with OR4A48P are −0.001009753 and
−0.01482009, respectively. Hence, the former locus becomes the DPL because of its smaller neg-
ative correlation. Thus, there is a very complex interplay among the different genes, their SNPs
and among the SNPs of different genes. In general it is infeasible to keep track of these complex
dependencies and provide simple explanations for the different DPLs and their differences with
the SNPs believed to be important by the scientific community.
The above elucidations attempt to point out that unless gene-gene and SNP-SNP interactions
are taken into account through a sophisticated, nonparametric framework, such complex interaction
effects might have been missed, which would perhaps lead to declaration of some truly influential
SNPs as non-significant, and some non-influential SNPs as influential.
5.3.4. Posteriors of the number of distinct mixture components distinguishing important
sets of genes Figures S-10, S-11 and S-12 show the posteriors of the number of distinct compo-
nents associated with genes from the sets {WDR12, FTO, SMARCA4, ZNF652}, {HLA −
DRA, RP11 − 306G20.1, PCSK9, ADCY 5} and {AP006216.10, APOC1, OR4A48P}, re-
spectively. The posteriors confirm our expectation that the four broad sub-populations composed
of Caucasians, Han Chinese, Japanese and Yoruban admit further sub-divisions in general. Indeed,
although for genes FTO, SMARCA4 and ZNF652, the number of subpopulations turned out to
be less than 5 with high posterior probabilities, for the other genes the number of subpopulations
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have exceeded 5 with almost full posterior probabilities. The shown posteriors are negligibly dif-
ferent for case and control, for all the three sets of genes, which is to be expected because of the
high positive correlations between λj0 and λj1.
It is interesting to observe that the posteriors of the number of components of the first set
of genes {WDR12, FTO, SMARCA4, ZNF652} are roughly stochastically dominated by the
second set {HLA−DRA, RP11−306G20.1, PCSK9, ADCY 5}, which, in turn, are dominated
by those of the set {AP006216.10, APOC1, OR4A48P}. The implication is that the third set
consists of more genetic variations, followed by the second set, while the first set consists of least
genetic variations. Thus, the last set of genes, consisting of only one locus each, seems to be most
likely to affect the disease, while the first set seems to be the least influential on MI.
5.4 Discussion of our Bayesian methods and GWAS in light of our findings
Our Bayesian analysis yielded results that are broadly in agreement with those obtained by GWA
investigations reported in the literature. However, the fact that some of the SNPs which are flagged
by the literature as important, did not show up as the most significant ones, deserves attention. The
main issue that emerged in our investigation is that the gene-gene interactions are responsible for
suppression of the so-called important SNPs via implicit induction of negative correlations among
Euclidean distances between cases and controls for the associated genes. Had there been no such
negative correlations, it is plausible that these SNPs would turn out to be the most influential ones.
Apart from a few agreements, the literature based SNPs are different from the SNPs detected
significant in our analysis, many of which lie in the intronic regions and have not been thoroughly
explored and hence need further investigation. As per our investigation, sophisticated, nonpara-
metric modeling of gene-gene interactions plays a very crucial role in imparting significance to
the overall effect of the individual genes. Since the GWAS did not incorporate the complex intra
and inter-genetic interactions into the model, it is perhaps not very unreasonable to question if the
same genes would emerge as significant if realistic modeling of gene-gene interactions is taken
into account.
For the current MI study, we summarize our findings in Tables 5.1 and 5.2, where we present the
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32 genes ordered with respect to the median case-control Euclidean distances, the SNPs flagged by
the literature as significant, the corresponding SNPs detected by our Bayesian model and methods,
and the phenotypes of the reportedly significant SNPs and our SNPs.
6. CONCLUDING REMARKS
In this work we have focused exclusively on gene-gene interaction. Recently, Bhattacharya &
Bhattacharya (2017b) and Bhattacharya & Bhattacharya (2017a) have extended this model to in-
corporate gene-environment interactions in our model, and developed tests for the effects of gene-
environment interactions as well as gene-gene interactions on case-control. They have successfully
applied the ideas to various simulated datasets generated from the GENS2 software, and to the MI
dataset, considering sex as the environmental variable. The results they obtained are broadly in
agreement with the results on this MI dataset already existing in the literature.
In this paper, we were compelled to consider a small part of the available real dataset consisting
of SNPs cited in the literature as important. This small dataset, however, has the added advantage
of alleviating computational burden. Indeed, since only 50 two-threaded cores were available to us
for implementation of our ideas, it is anyway imperative for us to confine attention to a (relatively
small) subset of the available dataset. We are, however, expecting to expand our current parallel
computing infrastructure, which would be of immense help in analysing the complete dataset,
which is our actual goal.
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Table 5.1: Summary of the MI data investigation, where genes are ranked in order of their decreas-
ing case-control based Euclidean distance.
Chr Literature Reported Bayesian Reported
Genes No. based SNPs Phenotype SNPs Phenotype
OR4A48P 11 rs7395662 LDL, HDL, rs7395662 LDL, HDL,
tryglycerides tryglycerides
AP006216.10 11 rs964184 triglycerides, LDL, rs964184 triglycerides, LDL,
HDL cholesterol HDL cholesterol
APOC1 19 rs4420638 LDL, HDL rs4420638 LDL, HDL
cholesterol cholesterol
TFAP2B 6 rs987237 BMI rs2011201
AP006216.5 11 rs7396835 Body weight, BMI rs1263172
triglyceride
RAB11B 19 rs2967605 Carotid Artery rs2913973
heart disease
BUD13 11 rs28927680 HDL, cholesterol rs10488699 LDL, cholesterol
triglycerides HDL cholesterol
CELSR2 1 rs599839 CHD, CAD, rs14000 CHD
LDL cholesterol
RP1-99E18.2 6 rs6922269 CHD rs11155760
WDR12 2 rs6725887 CHD, CAD, MI rs10205697
C6orf106 6 rs2814944 HDL, LDL, BMI rs1201872
cholesterol
HLA-DRA 6 rs3177928 cholesterol, LDL rs1051336
RP11-306G20.1 7 rs11556924 rs10265116
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Table 5.2: Continuation of Table 5.1.
Chr Literature Reported Bayesian Reported
Genes No. based SNPs Phenotype SNPs Phenotype
PCSK9 1 rs2479409 cholesterol, rs2182833 cholesterol
LDL cholesterol
ADCY5 3 rs2877716 Carbohydrate metabolism rs10934643
HMGCR 5 rs3846662 LDL cholesterol rs12654264
GALNT2 1 rs4846914 cholesterol, HDL rs1474925
Triglycerides
MRAS 3 rs9818870 CAD rs1199335
ZNF652 17 rs16948048 Diastolic blood rs12940887
pressure
ANKS1A 6 rs17609940 CAD rs17647222
SLC22A1 6 rs1564348 LDL rs1564348
RP11-136O12.2 8 rs17321515 Triglycerides rs16900615
GPAM 10 rs1129555 LDL rs10885315
RBMS1 2 rs7593730 Type 2 diabetes rs11694165
BDNF-AS 11 rs1013442 Smoking rs1013442
SMARCA4 19 rs1122608 MI(early onset) rs10415811
FTO 16 rs1121980 BMI rs10521303
MIA3 1 rs17465637 MI(early onset) rs17163303
CDKAL1 6 rs10946398 Type 2 diabetes rs1012625
ADAMTS9-AS2 3 rs4607103 Type 2 diabetes rs10510917
COL4A1 13 rs3742207 Arterial stiffness rs1000989
PHACTR1 6 rs12526453 MI (early onset) rs1014342
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Supplementary Material
S-1. A RULE OF THUMB FOR CHOOSING M AND α
Following Majumdar et al. (2013), Mukhopadhyay et al. (2012), Mukhopadhyay et al. (2011),
Bhattacharya (2008), we set M = 30 in our applications. It follows from Antoniak (1974) that
the mean and variance of the distinct parameter vectors in the set p1jk,p2jk, . . . ,pMjk are both
given by approximately αjk log
(
1 + M
αjk
)
. When prior information regarding the true number of
mixture components is lacking, it may be reasonable to specify the expected number of distinct
components to be close to half of the maximum number of components possible, namely, close
to M/2. With M = 30, we fix αjk = 10, so that about 14 distinct mixture components are
to be expected a priori. Apart from this choice, we also considered the possibilities αjk = 1,
αjk ∼ Gamma (0.1, 0.1), that is, the gamma distribution with mean 1 and variance 10, and αjk ∼
Gamma (1, 0.1) (so that the mean and variance are 10 and 100, respectively); however, the choice
αjk = 10 for all (j, k) outperformed the other choices with regard to capturing the true number
of mixture components. Hence, in this work, we report all our results associated with M = 30
and αjk = 10. According to this specification, the prior mean and variance of the number of
distinct components are approximately 14. Thus, compared to smaller values of αjk, this choice
ensures greater variability so that data-driven inference on the number of components receives
greater weight.
S-2. CHOICES OFA0 AND Σ0
For k = 0, 1; i = 1, . . . , Nk and j = 1, . . . , J , here we denote by wrijk the count of the minor allele
at the r-th locus of the j-th gene and k-th case-control status. In other words, wrijk = x
1
ijkr + x
2
ijkr.
With this notation we define
w¯ijk =
1
Lj
Lj∑
r=1
wrijk. (S-2.1)
Also let
w¯·j· =
1
N0 +N1
1∑
k=0
Nk∑
i=1
w¯ijk. (S-2.2)
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With these, we specify the (j1, j2)-th element ofA0 as
a0,j1j2 =
1
N0 +N1
1∑
k=0
Nk∑
i=1
(w¯ij1k − w¯·j1·) (w¯ij2k − w¯·j2·) . (S-2.3)
For the specification of Σ0, we first consider
w¯··k =
1
NkJ
Nk∑
i=1
J∑
j=1
w¯ijk. (S-2.4)
Then, letting N = min{N0, N1}, we specify the (k1, k2)-th element of Σ as
σ0,k1k2 =
1
NJ
N∑
i=1
J∑
j=1
(w¯ijk1 − w¯··k1) (w¯ijk2 − w¯··k2) . (S-2.5)
S-3. ELUCIDATION THAT THE R-TH LOCI OF ANY TWO DIFFERENT GENES
CAN BE INDEPENDENT WITH POSITIVE PROBABILITY
Our assumption that ur and vr of each locus r is shared by all the genes does not imply that the
labels of the loci of the genes are not exchangeable. Indeed, the r-th loci of two different genes
may be independent, given the data. To understand this, note that the r-th loci of any gene j does
not only have the effect ur and vr, but also λjk, for given k ∈ {0, 1}. In other words, all the
loci of gene j share the common effect λjk. Hence, for any two genes denoted by j1 and j2, and
k1, k2 ∈ {0, 1}, and considering only ur, the r-th loci have the effects ur +λj1k1 and ur +λj2k2 . By
our distributional assumptions it follows that the covariance between these effects is 1+aj1j2σk1k2 ,
given aj1j2 and σk1k2 , which is equal to zero if aj1j2 = −σ−1k1k2 . Independence follows due to
normality of our specified distributions. Now note that by our inverse-Wishart priors onA and Σ,
the event
∣∣aj1j2 + σ−1k1k2∣∣ <  gets positive probability for any  > 0, so that the covariance can be
in any neighborhood of zero with positive probability, if connoted by the data.
S-4. A PARALLEL MCMC ALGORITHM FOR MODEL FITTING
Recall that the mixtures associated with gene j ∈ {1, . . . , J} and case-control status k ∈ {0, 1}
are conditionally independent of each other, given the interaction parameters. This allows us to
update the mixture components in separate parallel processors, conditionally on the interaction
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parameters. Once the mixture components are updated, we update the interaction parameters us-
ing a specialized form of TMCMC, in a single processor. The details of updating the mixture
components in parallel are as follows.
(1) Split the pairs {(j, k) : j = 1, . . . , J ; k = 0, 1} in the available parallel processors.
(2) During each MCMC iteration, for each (j, k) in each available parallel processor, do the
following
(i) For i = 1, . . . , Nk, update the allocation variables zijk by simulating from the full
conditional distribution of zijk, given by
[zijk = m| · · · ] ∝ pimjk
Lj∏
r=1
f (xijkr|pmjkr) ; (S-4.1)
for m = 1, . . . ,M .
(ii) Let
{
p∗1jk, . . . ,p
∗
τjkjk
}
denote the distinct elements in PMjk =
{
p1jk, . . . ,pMjk
}
.
Also let Cjk = {c1jk, . . . , cMjk} denote the configuration vector, where cmjk = ` if
and only if pmjk = p∗`jk.
Now let τ (m)jk denote the number of distinct elements in P−Mjkm = P \
{
pmjk
}
and
let pm∗` =
{
pm∗`jkr; r = 1, . . . , Lj
}
; ` = 1, . . . , τ
(m)
jk denote the distinct parameter
vectors. Further, let pm∗` occur M`m times.
Then update cmjk using Gibbs steps, where the full conditional distribution of cmjk is
given by
[cmjk = `| · · · ] ∝
 q∗`,mjk if ` = 1, . . . , τ
(m)
jk ;
q0,mjk if ` = τ
(m)
jk + 1,
(S-4.2)
where
q0,mjk = αjk
Lj∏
r=1
β (n1mjr + ν1jkr, n2mjr + ν2jkr)
β (ν1jkr, ν2jkr)
; (S-4.3)
q∗`,mjk = M`m
Lj∏
r=1
{
pm∗`jkr
}n1mjr {1− pm∗`jkr}n2mjr . (S-4.4)
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In (S-4.3) and (S-4.4), n1mjr and n2mjr denote the number of “a” and “A” alleles,
respectively, at the r-th locus of the j-th gene associated with the m-th mixture compo-
nent. In other words, n1mjr =
∑
i:zijk=m
(
x1ijkr + x
2
ijkr
)
and n2mjr =
∑
i:zijk=m
{
2− (x1ijkr + x2ijkr)}.
The function β(·, ·) in the above equations is the Beta function such that for any
s1 > 0, s2 > 0, β(s1, s2) =
Γ(s1)Γ(s2)
Γ(s1+s2)
; Γ(·) being the Gamma function.
(iii) Let n∗1`jr =
∑
m:cmjk=`
n1mjr and n∗2`jr =
∑
m:cmjk=`
n2mjr. Then, for ` = 1, . . . , τjk;
r = 1, . . . , Lj; j = 1, . . . , J and k = 0, 1, update p∗`jkr by simulating from its full
conditional distribution, given by
[p∗`jkr| · · · ] ∼ Beta
(
n∗1j`r + ν1jkr, n
∗
2j`r + ν2jkr
)
. (S-4.5)
(3) During each MCMC iteration, update the interaction parameters {(ur′ , vr′); r′ = 1, . . . , L},
Λ,A and Σ in a single processor using TMCMC, conditionally on the remaining parameters.
The details of updating the interaction parameters are provided in Section S-4.1.
S-4.1 Updating the interaction parameters using a mixture of additive and additive-multiplicative
TMCMC
We now provide details on updating the parameters {(ur′ , vr′); r′ = 1, . . . , L}, Λ,A and Σ. Note,
however, that since A and Σ are positive definite matrices, directly updating these matrices is not
straightforward, since the MCMC proposals need not preserve positive definiteness and checking
positive definiteness, which is required while evaluating the acceptance ratio, is not straightforward
for high dimensional matrices. Therefore, we resort to Cholesky decompositions,A = C1C ′1 and
Σ = C2C
′
2, where C1 and C2 are lower triangular matrices. Thus, instead of updating A and
Σ directly, we can update the elements of C1 and C2, with the only constraint that the diagonal
elements are positive.
Before we provide the problem-specific details, let us first recall the main ideas of additive,
multiplicative, and additive-multiplicative TMCMC; for details see Dutta & Bhattacharya (2014)
and Dey & Bhattacharya (2016).
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S-4.1.1. Additive TMCMC Suppose that we are simulating from a d dimensional space
(usually Rd), and suppose we are currently at a point x = (x1, . . . , xd). Let us define d random
variables b1, . . . , bd, such that, for i = 1, . . . , d,
bi =
 +1 with probability pi;−1 with probability 1− pi. (S-4.6)
The additive TMCMC uses moves of the following type:
(x1, . . . , xd)→ (x1 + b1, . . . , xd + bd),
where  ∼ g(1) = q(1)(·)I{>0}. Here q(1)(·) is an arbitrary density with support R+, the posi-
tive part of the real line, and for any set A, IA denotes the indicator function of A. We define
T
(1)
b (x, ) = (x1 + b1, . . . , xd + bd) to be the additive transformation of x corresponding to the
‘move-type’ b. In our applications, we shall assume that pi = 1/2 for i = 1, . . . , d.
Thus, a single  is simulated from q(1)(·)I{>0}, which is then either added to, or subracted
from each of the d co-ordinates of x with probability 1/2. Assuming that the target distribution
is proportional to pi, the new move T (1)b (x, ), corresponding to the move-type b, is accepted with
probability
α = min
{
1,
pi(T
(1)
b (x, ))
pi(x)
}
. (S-4.7)
S-4.1.2. Multiplicative TMCMC Again suppose that we are simulating from a d dimensional
space (say, Rd), and that we are currently at a point x = (x1, . . . , xd). Let us now modify the
definition of the random variables b1, . . . , bd, such that, for i = 1, . . . , d,
bi =

+1 with probability pi;
0 with probability qi;
−1 with probability 1− pi − qi.
(S-4.8)
Let  ∼ g(2) = q(2)(·)I{||≤1}. If bi = +1, then xi → xi, if bi = −1, then xi → xi/ and if
bi = 0, then xi → xi, that is, xi remains unchanged. Let the transformed co-ordinate be denoted
by x∗i . Also, let J(b, ) denote the Jacobian of the transformation (x, ) 7→ (x∗, ). We denote x∗
by T (2)b (x, ), the multiplicative transformation (x, ) 7→ (x∗, ) associated with the move-type b.
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For example, if d = 2, then for b = (1, 1), T (2)b (x, ) = (x1, x2) and the Jacobian is 
2, for
b = (−1,−1), T (2)b (x, ) = (x1/, x2/) and |J(b, )| = −2. For b = (1,−1), b = (−1, 1), and
b = (0, 0), T (2)b (x, ) = (x1, x2/), (x1/, x2), and (x1, x2), respectively, and in all these three
instances, |J(b, )| = 1. For b = (1, 0) and b = (0, 1), T (2)b (x, ) = (x1, x2) and T (2)b (x, ) =
(x1, x2), respectively, and in both these cases |J(b, )| = ||. For b = (−1, 0) or b = (0,−1),
T
(2)
b (x, ) = (x1/, x2) and (x1, x2/), respectively, and the Jacobian is ||−1 in both these cases.
In general, the Jacobian for multiplicative TMCMC is given by ||∑di=1 bi .
For our purpose, we assume that pi = qi = 1/3; i = 1, . . . , d. Then assuming that the target
distribution is proportional to pi, the new move T (2)b (x, ) is accepted with probability
α = min
{
1,
pi(T
(2)
b (x, ))
pi(x)
|J(b, )|
}
. (S-4.9)
S-4.1.3. Additive-Multiplicative TMCMC Dutta & Bhattacharya (2014) described another
TMCMC algorithm that uses the additive transformation for some co-ordinates of x and the mul-
tiplicative transformation for the remaining co-ordinates. Dutta & Bhattacharya (2014) refer to
this as additive-multiplicative TMCMC. Let the target density pi be supported on Rd. Then, if
the additive transformation is used for the i-th co-ordinate, we update xi to xi + bi1, where bi is
defined by (S-4.6), and  ∼ g(1). On the other hand, if for any co-ordinate xj , the multiplicative
transformation is used, then we simulate bj following (S-4.8), simulate 2 ∼ g(2), and update xj to
either xj2 or xj/2 accordingly as bj = +1 or −1. If bj = 0, then we leave xj unchanged. The
new proposal is accepted with probability having the same form as (S-4.9). Note that unlike the
cases of additive TMCMC and multiplicative TMCMC, which use a single  to update all the d
co-ordinates of x, here we need two ’s: 1 and 2, to update the d co-ordinates.
S-4.1.4. Mixture of additive and additive-multiplicative TMCMC for updating the interac-
tion parameters Note that additive TMCMC is expected to make shorter jumps, which maintain
high acceptance rate, while multiplicative TMCMC makes longer jumps on the average, which
improves mixing behaviour of the underlying Markov chain. Hence, it is expected that a mixture
of additive and multiplicative TMCMC should outperform the two individual TMCMC strategies.
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Dey & Bhattacharya (2016) demonstrate with simulation studies that this is indeed the case.
For our purpose, we consider a mixture of additive and additive-multiplicative TMCMC, giving
equal weight to both, for updating the interaction parameters. In the additive-multiplicative TM-
CMC we update {(ur′ , vr′) ; r′ = 1, . . . , L}, Λ, and the diagonal elements of the lower triangular
matrices C1 and C2, using the additive transformation, while using the multiplicative transforma-
tion to update the off-diagonal elements of C1 and C2.
Implementation of mixture TMCMC with equal mixing weights involves, for each iteration
of TMCMC, simulating a random number R ∼ U(0, 1); if R < 1/2, additive TMCMC is to be
employed. Otherwise, additive-multiplicative TMCMC must be implemented. The acceptance
ratio (without the Jacobian) is obtained by evaluating
pi(Λ)pi(C1C
′
1)pi(C2C
′
2)×
d∏
`=1
J∏
j=1
1∏
k=0
Lj∏
r=1
{
p∗`jkr
}n∗1j`r+exp(ur+λjk) {1− p∗`jkr}n∗2j`r+exp(vr+λjk)
at the proposed and the old values of the interaction parameters, conditionally on the remaining
parameters. In the above, pi(Λ), pi(C1C ′1) and pi(C2C
′
2) are given by (3.15), (3.21) and (3.23) of
our main manuscript.
In our applications we chose  ∼ g(1) ≡ N(0, 1)I{>0} for additive transformations and η ∼
g(2) ≡ N(0, 1)I{|η|<1} for multiplicative transformations. It is also important to mention that in our
applications of additive transformation, we considered the positive scaling factors ϕ1, . . . , ϕd, so
that the transformation takes the form
(x1, . . . , xd)→ (x1 + b1ϕ1, . . . , xd + bdϕd).
For {(ur′ , vr′); r′ = 1, . . . , L} and Λ, choosing all the scale factors to be 0.01 and choosing the
relevant scale factors to be 0.05 in the cases of C1 and C2 yielded reasonable convergence.
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S-5. HELLINGER DISTANCE FOR HYPOTHESIS TESTING AND ASSOCIATED
COMPUTATIONAL CHALLENGE
An appropriate divergence measure between any two probability distributions f1 and f2 over the
same domain Y is the Hellinger distance given by
d(f1, f2) =
√
1−BC(f1, f2), (S-5.1)
where BC(f1, f2) is the Bhattacharyya coefficient (Bhattacharyya (1943)), given, in the discrete
case, by
BC(f1, f2) =
∑
y∈Y
√
f1(y)f2(y). (S-5.2)
It is well-known that d(f1, f2) defined as (S-5.1), is a metric.
In our situation, h0j and h1j are distributions of Lj-variate binary random variables, so that the
support is {0, 1}Lj . For large Lj , this renders the BC coefficient (S-5.2) infeasible to compute.
Indeed, in our applications, Lj is of the order of thousands, and this compels us to seek alternatives
to the Hellinger metric.
S-6. CLUSTERING AND EUCLIDEAN METRICS
S-6.1 Computationally efficient alternative based on clustering ideas
Ideas on clusterings of the mixture distributions h0j and h1j provides us with a novel and com-
putationally efficient procedure for testing H0. Briefly, we assess discrepancies between the
two mixture distributions h0j and h1j by studying the divergence between the two clusterings
of PMjk=0 =
{
p1jk=0,p2jk=0, . . . ,pMjk=0
}
and PMjk=1 =
{
p1jk=1,p2jk=1, . . . ,pMjk=1
}
, for
j = 1, . . . , J . Significantly large divergence between the two clusterings for some j = 1, . . . , J
clearly leads to rejection ofH0. An appropriate metric for studying divergence between clusterings
is described next.
S-6.1.1. Choice of the clustering metric To avoid computational burden we work with the
following clustering metric suggested by Mukhopadhyay et al. (2011) as an approximation to the
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one coined by Ghosh et al. (2009):
dˆ(I, II) = max
{
d¯(I, II), d¯(II, I)
}
, (S-6.1)
where
d¯(I, II) =
{
n˜00 −
K1∑
i=1
max
1≤j≤K2
n˜ij
}/
n˜00 (S-6.2)
= 1−
∑K1
i=1 max1≤j≤K2
n˜ij
n˜00
. (S-6.3)
S-6.1.2. Shortcoming of the clustering metric for hypothesis testing Significantly large di-
vergence between clusterings of PMjk=0 and PMjk=1 indicate significant difference between the
mixture densities h0j and h1j . However, insignificant clustering distance between PMjk=0 and
PMjk=1 need not necessarily imply insignificant difference between the above mixture densities.
As a simple example, let us consider two different parameter vectors {θ1, θ1, θ2} and {ϑ1, ϑ1, ϑ2}.
Although these two vectors have the same clustering {{1, 2}, {3}}, the parameter vectors them-
selves may be significantly different. Therefore, whenever the clustering distance is insignificant,
it is important to check whether or not the parameter vectors being compared, are significantly
different. We next propose a divergence based on the Euclidean distance between two vectors for
this purpose.
S-6.2 Divergence based on Euclidean metric in conjunction with the clustering metric for
hypothesis testing
Note that when two clusterings are the same, minimizing the Euclidean distance over all possible
permutations of the clusters, provides a sensible measure of divergence. In other words, for any
two vectors v(1) =
(
v
(1)
1 , . . . , v
(1)
K
)
and v(2) =
(
v
(2)
1 , . . . , v
(2)
K
)
inK-dimensional Euclidean space,
where K > 1, we propose the following divergence measure:
d
E,min
(
v(1),v(2)
)
= min
j1,...,jK
√√√√ K∑
i=1
(
v
(1)
i − v(2)ji
)2
, (S-6.4)
the minimization being over all possible permutations (j1, j2, . . . , jK) of (1, 2, . . . , K).
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Note that the maximum or the average over all possible permutations is not appropriate –
even when the two vectors being compared are the same, taking maximum or average over the
permutations results in non-zero divergence. The above divergence is non-negative, symmetric
in that d
E,min
(
v(1),v(2)
)
= d
E,min
(
v(2),v(1)
)
, satisfies the property d
E,min
(
v(1),v(2)
)
= 0 if
and only if v(1) = v(2), and is invariant with respect to permutations of the clusters. However,
we refer to d
E,min as a pseudo-metric as the divergence measure does not satisfy the triangular
inequality. Failure of the triangle inequality is not unusual, a very well-known instance being
the Kullback-Leibler divergence. See also Basu, Shioya & Park (2011) for the general class of
divergence measures which do not satisfy the triangular inequality. Hence, we do not perceive
d
E,min as suffering from any serious drawback.
S-6.2.1. Strategy for avoiding minimization over permutations Since the number of possi-
ble permutations can be quite large, computation of d
E,min can be burdensome in the extreme for
large number of MCMC iterations. Hence, we consider the following strategy for actual testing of
hypothesis using d
E,min when the null hypothesis has been accepted by the clustering based test.
We first test the hypothesis using the simple Euclidean metric dE after attaching significant
weight to the null hypothesis. Since dE ≥ dE,min, acceptance of the null hypothesis with respect
to dE implies acceptance of the null with respect to dE,min. The strategy of providing preference to
the null is justifiable on the ground that the clustering metric has already provided partial evidence
in favour of the null that at least the clusterings are not significantly different.
If the null hypothesis is accepted with respect to dE , then we have clearly been able to avoid
minimization over permutations. If, on the other hand, the null is rejected when tested with dE ,
then one must re-test the null using d
E,min, which would involve dealing with permutations.
S-6.2.2. Computation of the simple Euclidean metric in our case after logit transforma-
tion In our case, in order to compute the simple Euclidean distance, we first compute the averages
p¯mjk =
∑Lj
r=1 pm,jkr/Lj , then consider their logit transformations logit (p¯mjk) = log {p¯mjk/(1− p¯mjk)}.
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Then, we compute the Euclidean distance between the vectors
logit
(
P¯Mjk=0
)
= {logit (p¯1jk=0) , logit (p¯2jk=0) , . . . , logit (p¯Mjk=0)}
and
logit
(
P¯Mjk=1
)
= {logit (p¯1jk=1) , logit (p¯2jk=1) , . . . , logit (p¯Mjk=1)} .
We denote the Euclidean distance associated with the j-th gene by
dE,j = dE,j
(
logit
(
P¯Mjk=0
)
, logit
(
P¯Mjk=1
))
, and denote max
1≤j≤J
dE,j by d∗E .
S-7. SIMULATION STUDIES
S-7.1 First simulation study: gene-gene interaction
S-7.1.1. Data description In the first simulation study we simulated 5 case-control type data
sets associated with 5 different sub-populations in the context of gene-gene interaction associated
with two genetic factors. The data sets consist of disease status, gender, environmental exposures
and genotypes for each individual. Two genes have been considered, one with 1084 SNPs and
another with 1206 SNPs, with one DPL at each gene. Each of the 5 data sets consists of 113
individuals. From the 5 data sets, we selected a total of 100 individuals without replacement with
probabilities assigned to the 5 data sets being (0.1, 0.4, 0.2, 0.15, 0.15). That is, we chose one of
the 5 data sets with these probabilities and selected a row randomly from the chosen data set; we
repeated this procedure 100 times without replacing the rows. In our final data set thus obtained,
there were 41 cases and 59 controls arising out of 5 different sub-populations.
S-7.1.2. Specifications of the thresholds ε’s using null distributions Before testing the
relevant hypotheses, it is important to discuss how to choose the thresholds ε’s associated with
the hypotheses. Our idea is to study the null distribution of the distance measures in connection
with the clusterings of the parameter vectors of the mixture distributions associated with a gene
in cases and controls, using which we specify the thresholds. In more details, we simulate a
genotype data set using our own Bayesian semiparametric model, considering two genes, the genes
consisting of L1 = 1084 and L2 = 1206 SNPs, respectively, as in the original data set obtained
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from GENS2. We also set N1 + N2 = 100. To guarantee that there is no interaction between
the genes, we set A to be the identity matrix. We also set Σ to be the identity matrix. For each
gene j, and for control status k = 0, we simulate PMjk=0 using the Polya urn scheme, and set
PMjk=1 = PMjk=0, independently for j = 1, 2; this ensures that for each gene, case and control
are associated with exactly the same mixture, and that the genes are unrelated to each other. Fitting
our model to the data generated from the GENS2 software showed that about 5 distinct mixture
components are highly probable for each (j, k). Since our past research on our Dirichlet process
based mixture model (Bhattacharya (2008), Mukhopadhyay et al. (2011), Mukhopadhyay et al.
(2012), Majumdar et al. (2013)) revealed that it is a reliable representative of the true number of
components, we assume that approximately 5 components are to be expected for each (j, k). As
such, we set αjk = 1.5 so that αjk log
(
1 + M
αjk
)
≈ 5 is (approximately) the expected number of
components. We set αjk = 1.5 for generating the data from our model as well as for fitting our
model to this generated data. Thus, about 5 components are expected both a priori and a posteriori.
It is also important to note that, although we set A and Σ to be identity matrices while gener-
ating the data, we fit our model to the data using the general set-up described in Sections 3.3.4 and
3.3.5 of our main manuscript.
Hence, fitting our model to the data set generated under the absence of genetic and interaction
effects are expected to yield posterior distributions of the relevant quantities which can serve as
benchmark distributions under the null hypotheses. We generate posterior samples using the same
parallel MCMC algorithm detailed in Section S-4. of the supplement.
We specify ε’s as F−1 (0.55), where F is the distribution function of the relevant benchmark
posterior distribution. The reason for choosing F−1 (0.55) instead of the median is to ensure that
the correct null hypothesis is accepted under the “0− 1” loss. Indeed, for the median, the posterior
probability of the true null is 0.5, while under the “0− 1” loss, the true null will be accepted if its
posterior probability exceeds 1/2.
S-7.1.3. Results of fitting our model We implemented our parallel MCMC algorithm on a ma-
chine with i7 processors, splitting the mixture updating mechanisms in 4 parallel processors, and
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updating the interaction parameters in a single processor. Our code is written in C in conjunction
with the Message Passing Interface (MPI) protocol for parallelisation.
The total time taken to implement 30, 000 MCMC iterations, where the first 10, 000 are dis-
carded as burn-in, is just about an hour. Informal convergence assessment with trace plots indicated
reasonably good mixing.
Figure S-1 displays the posterior distributions of d∗ = max
j=1,2
dˆ (P 30,j,0,P 30,j,1), dˆ1 = dˆ (P 30,1,0,P 30,1,1)
and dˆ2 = dˆ (P 30,2,0,P 30,2,1), respectively. The diagrams show that in all the three cases, regions
that are significantly bounded away from zero have high posterior probabilities compared to those
closer to zero. For the purpose of formal Bayesian hypothesis, following the discussion in Section
S-7.1.2, we set ε = 0.233. Then the posterior probability P (d∗ < ε|Data), empirically obtained
from 20, 000 MCMC samples, turned out to be 0.230. With c = 1 in the “0 − 1 − c” loss (so that
the popular “0 − 1” loss is obtained), this is far less than the threshold posterior probability 1/2.
That is, under the “0− 1” loss, our Bayesian test of hypothesis clearly suggests significant overall
genetic influence.
It now remains to investigate individual and interaction effects of the genes. The empirical
posterior probabilities P
(
dˆ1 < ε|Data
)
and P
(
dˆ2 < ε|Data
)
turned out to be 0.242 and 0.280,
respectively, where we obtained ε = 0.2. Under the “0− 1” loss, our tests thus suggest significant
individual genetic effects.
Using the procedure detailed in Section S-7.1.2, we obtain ε = 0.166. The relevant empir-
ical posterior probability is given by P (|A12| < 0.166|Data) ≈ 0.326, clearly pointing towards
significant gene-gene interaction under the “0− 1” loss.
Finally,the true numbers of sub-populations have been correctly captured by our model and
methodologies. Figure S-2 shows that although we started out with a maximum of M = 30 com-
ponents for each (j, k); j = 1, 2; k = 0, 1, the posterior distribution of the number of components
in all the four pairs of (j, k) have correctly concentrated around 5, the true number of components.
Once again, this is highly encouraging.
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(a) Posterior of d∗.
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(b) Posterior of dˆ1.
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(c) Posterior of dˆ2.
Figure S-1: Gene-Gene Interaction: Posterior distributions of d∗ = max
j=1,2
dˆ (PMjk=0,PMjk=1)
(panel (a)), dˆ1 = dˆ (PMjk=0,PMjk=1), with j = 1 (panel (b)) and dˆ2 = dˆ (PMjk=0,PMjk=1),
with j = 2 (panel (c)). In all the cases, M = 30.
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(a) Posterior of τ10.
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(b) Posterior of τ11.
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(c) Posterior of τ20.
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(d) Posterior of τ21.
Figure S-2: Gene-Gene Interaction: Posterior distributions of the number of distinct components
τjk for each pair (j, k); j = 1, 2; k = 0, 1.
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S-7.1.4. Detection of DPL The case-control data simulated by the GENS2 software has one
DPL in each of the two genes with the positions given by rs13266634 and rs7903146, for the first
and second gene respectively. However, as both the genes contain thousands of loci along with one
DPL in each, with realistic patterns of Linkage Disequilibrium existing between them (see Pinelli
et al. (2012)), We propose a graphical method to single out the influential SNPs. The details are as
follows.
To check if the r-th locus of the j-th gene is disease producing, we assess if the Euclidean dis-
tance drj
(
prjk=0,p
r
jk=1
)
, between prjk=0 and p
r
jk=1, is significantly larger than d
r′
j
(
pr
′
jk=0,p
r′
jk=1
)
;
for r′ 6= r. Although formal tests of significance for each locus is also possible, such tests can be
computationally burdensome for large number of loci such as ours. Hence, here we adopt a graph-
ical approach based on index plots, in the spirit of detecting influential points in linear regression
analysis. Such informal plots are often advocated in statistics, see, for example, Chatterjee & Hadi
(2006) and the references therein.
In our case, for each gene j, we analyse the index plot of the Euclidean distances{
drj
(
logit
(
prjk=0
)
, logit
(
prjk=1
))
; r = 1, . . . , Lj
}
. The plots, for the first and the second gene,
are displayed in panels (a) and (b) of Figure S-3.
The red, horizontal lines in the diagrams represent the cut-off value such that the points above
the horizontal line are those with the highest 2% Euclidean distances. In panel (a) of Figure S-3, the
flagged point above the cut-off line, which is also associated with the maximum Euclidean distance,
corresponds to SNP position rs3802178. The figure also shows that the actual DPL rs13266634
is a very close neighbor of rs3802178. In panel (b) of Figure S-3, the actual DPL rs7903146 is
found to be lying very close to rs6585197, a SNP detected as influential by our method. That is,
our set of suspicious loci in the second gene again contains a very close neighbor of the true DPL.
Realistically, it is appropriate to further investigate all the SNPs with Euclidean distances on or
above the red, horizontal line, along with their close neighbors, as possible influential SNPs.
In spite of starting the investigation with simultaneous consideration of a large number of SNPs
under the existence of realistic patterns of LD and a stratified population structure, our model and
methodologies have not only detected the genetic and interaction effects correctly, but has also
45
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(a) Index plot for the first gene
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(b) Index plot for the second gene.
Figure S-3: Index plots: Plots of the Euclidean distances
{
drj
(
prjk=0,p
r
jk=1
)
; r = 1, . . . , Lj
}
against the indices of the loci, for j = 1 (panel (a)) and j = 2 (panel (b)).
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narrowed down the search for DPLs to a few influential SNPs, lying in the close neighborhoods of
the actual DPL. Given that we assumed no knowledge of the true model while fitting the data, this
is highly encouraging.
S-7.1.5. Results obtained after randomly permuting the labels of the loci in the dataset
We conducted a further simulation study after randomly permuting the labels of the loci of the
dataset. In this case, we obtained exactly the same thresholds ε as in the original simulation
study, and the probabilities P (d∗ < ε|Data), P
(
dˆ1 < ε|Data
)
and P
(
dˆ2 < ε|Data
)
are given,
approximately, by 0.055, 0.128 and 0.123, respectively, strongly suggesting significant overall
and marginal genetic effects. For gene-gene interaction effect, we obtained the threshold to be
ε = 0.137, and P (|A12| < ε|Data) ≈ 0.132, strongly suggesting significant gene-gene interaction.
Thus, the results associated with randomly permuted labels of the loci are very much in keeping
with the results of the original simulation study.
S-7.2 Second simulation study: no genetic effect
In this study, exactly in the same way as in the first simulation study, we simulated a mixture data
set consisting of 5 sub-populations with mixing proportions (0.1, 0.4, 0.2, 0.15, 0.15); the only
difference with the first simulation study being the absence of any genetic effect and presence of
the effect due environmental factor only. In a total of 100 individuals simulated, there were 49 cases
and 51 controls. For specification of the thresholds ε’s, we employ the same method proposed in
Section S-7.1.2.
We implement our model with the parallel MCMC algorithm in exactly the same way as in the
first simulation study, and obtained 30, 000 iterations with the first 10, 000 discarded as burn-in.
The posterior empirical probabilities P (d∗ < ε1|Data), P (d1 < ε2|Data) and P (d2 < ε3|Data),
where ε1 = 0.233, ε2 = ε3 = 0.2, turned out to be 0.554, 0.511, and 0.502, respectively. Note
that, under the “0 − 1” loss, the evidence associated with d∗ favours the hypothesis of no genetic
effect; the evidence is particularly strong because the posterior probability P (d∗ < ε1|Data) almost
exactly matches the corresponding posterior probability under the true null hypothesis of no genetic
47
effect. The same argument clarifies that the other two posterior probabilities P (d1 < ε2|Data)
and P (d2 < ε3|Data) also provide reasonably strong evidence against the hypothesis of genetic
influence.
To re-confirm the null hypotheses, we now resort to our tests based on the Euclidean metric.
Following the method proposed in Section S-7.1.2 we obtained the thresholds εE = 17.410, εE,1 =
16.250 and εE,2 = 16.307, for evaluating the relevant posterior probabilities, P (d∗E < εE|Data),
P (dE,1 < εE,1|Data) and P (dE,1 < εE,2|Data). These probabilities are evaluated to be approxi-
mately 0.118, 0.156, and 0.256, respectively. For c = 19 associated with the “0 − 1 − c” loss,
so that 1/(1 + c) = 0.05, the above hypotheses are clearly accepted at 5% level of significance,
ensuring that the genes are not responsible for the case-control status. In fact, more generally, for
c ≥ 9, implying that 1/(1 + c) ≤ 0.1, the above posterior probabilities ensure acceptance of the
hypotheses at levels of significances not exceeding 10%. Moreover, as in the first simulation study,
even in this case the true number of sub-populations has been well-captured by our model (figures
not shown).
Hence, all our results, under both the simulation studies, are very much in keeping with the
underlying true genetic information used for generating the data sets.
S-7.2.1. Results obtained after randomly permuting the labels of the loci in the dataset In
this case we obtained P (d∗ < ε|Data) ≈ 0.439, P
(
dˆ1 < ε|Data
)
≈ 0.519 and P
(
dˆ2 < ε|Data
)
≈
0.585. Although P (d∗ < ε|Data) did not cross 0.5, it is quite substantial, and in conjunction
with the above marginal posterior probabilities suggest no genetic effect. This is strongly con-
firmed by the tests based on the Euclidean metric, as P (d∗E < εE|Data), P (dE,1 < εE,1|Data) and
P (dE,1 < εE,2|Data) are approximately 0.794, 0.672 and 0.671, respectively, with respect to the
thresholds εE = 18.195, εE,1 = 16.502 and εE,2 = 16.510. Even P (|A12| < ε|Data) ≈ 0.582,
strongly suggesting insignificant gene-gene interaction.
In other words, again the results associated with random permutation of the labels of the loci
of the genes are consistent with the original simulation study and the truth.
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S-8. EXPLANATION OF THE ISSUE THAT EVEN SMALL CORRELATIONS
BETWEEN SNP-WISE CASE-CONTROL EUCLIDEAN DISTANCES
DETERMINE THE DPL
Let us consider the following example where (X, Y ) ∼ N2 (µX , µY , σ2X , σ2Y , ρ), that is, (X, Y ) are
distributed as bivariate normal with means µX , µY ; variances σ2X , σ
2
Y , and correlation ρ. Then, the
conditional expectation of Y given X = x is given by E[Y |X = x, ρ] = µY + σYσX ρx.
Now, for any positive integer n, suppose that we wish to find the maximum among
{
Yˆ1, . . . , Yˆn
}
,
where, for i = 1, . . . , n, Yˆi = E[Y |X = x, ρi] = µY + σYσX ρix. Clearly, the maximum will be Yˆi∗ ,
where i∗ = arg max
i∈{1,...,n}
ρi. In other words, irrespective of how small the values of {ρ1, . . . , ρn} are,
the maximum correlation among them dictates which value among
{
Yˆ1, . . . , Yˆn
}
will be the max-
imum.
In our case, the quantile-quantile plots indicate that the SNP-wise Euclidean distances are quite
close to normality, and since our goal is to find the maximum among the SNP-wise expectations
of the Euclidean distances (approximated by averaging over the TMCMC samples), the above
argument explains that indeed the correlations between the SNP-wise Euclidean distances, however
small in magnitude, dictate which SNP will be the DPL.
S-9. SOME OTHER SIGNIFICANT SNPS IN THE REAL DATA ANALYSIS
Figures S-6, S-7 and S-8 clearly indicate that in almost all the cases excepting the genes MIA3
and PHACTR1, the Euclidean distances of the significant SNP by our method agree quite closely
with the SNPs detected as significant in the earlier studies (see Lucas et al. (2012) and the refer-
ences therein). Note that for all the genes, including MIA3 and PHACTR1, the SNPs found
significant in other studies lie in close neighbourhood of our most significant SNP with respect to
the Euclidean distance; highlighting once again the need for close investigation of the SNPs lying
in the close neighbourhood of those with highest Euclidean distance.
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(a) Real Data Analysis: Posterior probability of no genetic effect with respect to clustering metric.
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(b) Real Data Analysis: Posterior probability of no genetic effect with respect to Euclidean metric.
Figure S-4: Posterior probabilities of no individual genetic influence: Index plots of the poste-
rior probabilities of the null hypotheses for (a) clustering metric and (b) Euclidean metric, for the
32 genes.
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(b) Euclidean metric medians.
Figure S-5: Posterior medians of the Euclidean distances: Index plots of the posterior medians
of the clustering metric and the Euclidean distance with respect to the 32 genes.
51
1 2 3 4 5
90
10
0
11
0
12
0
13
0
14
0
WDR12
Index
Eu
cl
id
ea
n 
di
st
an
ce
 b
et
we
e
n
 c
a
se
 a
n
d 
co
nt
ro
l
.
rs10205697
(DPL)
.
rs6725887
(a) DPL of WDR12.
0 20 40 60 80 100 120 140
0
10
0
20
0
30
0
40
0
FTO
Index
Eu
cl
id
ea
n 
di
st
an
ce
 b
et
we
e
n
 c
a
se
 a
n
d 
co
nt
ro
l
.
rs10521303
(DPL)
.
rs1121980
(b) DPL of FTO.
1 2 3 4 5
0
20
40
60
80
10
0
MIA3
Index
Eu
cl
id
ea
n 
di
st
an
ce
 b
et
we
e
n
 c
a
se
 a
n
d 
co
nt
ro
l
.
rs17163303
(DPL)
.
rs17465637
(c) DPL of MIA3.
5 10 15
0
50
10
0
15
0
SMARCA4
Index
Eu
cl
id
ea
n 
di
st
an
ce
 b
et
we
e
n
 c
a
se
 a
n
d 
co
nt
ro
l
.
rs10415811
(DPL)
.
rs1122608
(d) DPL of SMARCA4.
0 50 100 150
0
10
0
20
0
30
0
40
0
PHACTR1
Index
Eu
cl
id
ea
n 
di
st
an
ce
 b
et
we
e
n
 c
a
se
 a
n
d 
co
nt
ro
l
.
rs1014342
(DPL)
.
rs12526453
(e) DPL of PHACTR1.
2 4 6 8 10
16
0
17
0
18
0
19
0
20
0
21
0
22
0
C6orf106
Index
Eu
cl
id
ea
n 
di
st
an
ce
 b
et
we
e
n
 c
a
se
 a
n
d 
co
nt
ro
l
.
rs1201872
(DPL)
.
rs2814944
(f) DPL of C6orf106.
Figure S-6: Disease predisposing loci of other influential genes: Plots of the Euclidean dis-
tances against the indices of the loci of genesWDR12, FTO, MIA3, SMARCA4, PHACTR1,
C6orf106.
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Figure S-7: Disease predisposing loci of other influential genes: Plots of the Euclidean distances
against the indices of the loci of genes ZNF652, RAB11B, RP11 − 136O12.2, ANKS1A,
CELSR2, GPAM . The figures exhibit adequate agreement of our obtained DPLs and the loci
believed to be influential.
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(a) DPL of SLC22A1.
0 5 10 15 20 25 30 35
0
50
10
0
15
0
20
0
BDNF−AS
Index
Eu
cl
id
ea
n 
di
st
an
ce
 b
et
we
e
n
 c
a
se
 a
n
d 
co
nt
ro
l
.
rs1013442
(DPL)
(b) DPL of BDNF −AS.
0 50 100 150 200
0
10
0
20
0
30
0
40
0
CDKAL1
Index
Eu
cl
id
ea
n 
di
st
an
ce
 b
et
we
e
n
 c
a
se
 a
n
d 
co
nt
ro
l
.
rs1012625(DPL)
.
rs10946398
(c) DPL of CDKAL1.
Figure S-8: Disease predisposing loci for genes SLC22A1, BDNF −AS and CDKAL1: Our
DPLs remarkably agree with the existing influential SNPs. In fact, for SLC22A1 and BDNF −
AS, our DPLs coincide with the existing influential SNPs.
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Figure S-9: Presence/absence of gene-gene interactions: Blue denotes presence and white rep-
resents absence of gene-gene interaction.
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(d) Posterior of τ4,1.
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(e) Posterior of τ8,0.
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(f) Posterior of τ8,1.
Figure S-10: Posterior of number of components: Posterior distributions of the number of dis-
tinct components τj,k for each pair (j, k); j=2,4,8; k = 0, 1. The left and right panels show the
posteriors associated with cases and controls, respectively.
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(a) Posterior of τ13,0.
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(b) Posterior of τ13,1.
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(c) Posterior of τ25,0.
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(d) Posterior of τ25,1.
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(e) Posterior of τ30,0.
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(f) Posterior of τ30,1.
Figure S-11: Posterior of number of components: Posterior distributions of the number of dis-
tinct components τj,k for each pair (j, k); j = 13, 25, 30; k = 0, 1. The left and right panels show
the posteriors associated with cases and controls, respectively.
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(a) Posterior of τ6,0.
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(b) Posterior of τ6,1.
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(c) Posterior of τ19,0.
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(d) Posterior of τ19,1.
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(e) Posterior of τ27,0.
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(f) Posterior of τ27,1.
Figure S-12: Posterior of number of components: Posterior distributions of the number of dis-
tinct components τj,k for each pair (j, k); j = 6, 19, 27; k = 0, 1. The left and right panels show
the posteriors associated with cases and controls, respectively.
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